Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as $4.89 and last traded at $4.95, with a volume of 31345 shares changing hands. The stock had previously closed at $4.86.
Evotec Stock Up 1.9 %
The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The firm has a market cap of $1.63 billion, a PE ratio of 11.85 and a beta of 0.98. The stock has a fifty day simple moving average of $4.97 and a two-hundred day simple moving average of $7.11.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Recommended Stories
- Five stocks we like better than Evotec
- How to Choose Top Rated Stocks
- RXO Shares Surge Following New Acquisition Deal
- Short Selling: How to Short a Stock
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- What Are Dividends? Buy the Best Dividend Stocks
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.